SCHEMBL7412699

SCHEMBL7412699

O=C1OCc2c1cnc1ccccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 10/20 0.42
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
KDM4E B2RXH2 1/20 0.40
GPR3 P46089 1/20 0.40
KCNJ1 P48048 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
PDPK1 O15530 1/20 0.37
CA12 O43570 1/20 0.37
PARP1 P09874 1/20 0.37
ALOX15 P16050 1/20 0.37
CA9 Q16790 1/20 0.37
TNKS2 Q9H2K2 1/20 0.37
ERN1 O75460 1/20 0.37
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
TP53 P04637 1/20 0.35
MAPT P10636 1/20 0.35
PTK2B Q14289 1/20 0.35
SSTR2 P30874 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4072632 0.83 ALDH1A1 (0.42) MAOAMAOBKDM4EGPR3SMN1; SMN2
SCHEMBL8585832 0.71 GRM2 (0.47) KDM4EGPR3SMN1; SMN2PDPK1CA12
SCHEMBL28417673 0.71 MEN1 (0.42) MAOAMAOBKDM4EGPR3SMN1; SMN2
SCHEMBL8641190 0.69 ALOX5 (0.53) ALOX5MAOAMAOBKDM4EKCNJ1
SCHEMBL8874682 0.68 KDM4E (0.42) KDM4EGPR3SMN1; SMN2PDPK1CA12
SCHEMBL2199956 0.68 MAOA (0.34) ALOX5MAOAMAOBKDM4EKCNJ1
SCHEMBL1191742 0.68 MET (0.42) KDM4EGPR3SMN1; SMN2PDPK1CA12
SCHEMBL16836537 0.68 KDM4E (0.39) MAOAMAOBKDM4EGPR3SMN1; SMN2
SCHEMBL7404594 0.67 UGCG (0.49) KDM4ENPC1RAB9A
SCHEMBL23120251 0.67 KDM4E (0.38) KDM4EGPR3SMN1; SMN2PDPK1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5604235-A DIAGNOSIS AND TREATMENT OF ANXIETY, SLEEP AND SEIZURE DISORDERS, BENZODIAZEPINE OVERDOSE; ENHANCEMENT OF MEMORY NEUROGEN CORPORATION (US) 1997-02-18 US disclosed
WO-1994026741-A1 CERTAIN PYRROLOQUINOLINONES; A NEW CLASS OF GABE BRAIN RECEPTOR LIGANDS NEUROGEN CORPORATION (US) 1994-11-24 WO disclosed
US-5243049-A Gamma-aminobutyric acid antagonist NEUROGEN CORPORATION (US) 1993-09-07 US disclosed